Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study

AbstractObjective: Given the psychosocial and ethical burden, patients with hypertrophic cardiomyopathy (HCMs) could benefit from the establishment of genetic probability prior to the test. This study aimed to develop a simple tool to provide genotype prediction for HCMs.Methods: A convolutional neu...

Full description

Bibliographic Details
Main Authors: LaiTe Chen, GuoSheng Fu, ChenYang Jiang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2235564
_version_ 1827380472264523776
author LaiTe Chen
GuoSheng Fu
ChenYang Jiang
author_facet LaiTe Chen
GuoSheng Fu
ChenYang Jiang
author_sort LaiTe Chen
collection DOAJ
description AbstractObjective: Given the psychosocial and ethical burden, patients with hypertrophic cardiomyopathy (HCMs) could benefit from the establishment of genetic probability prior to the test. This study aimed to develop a simple tool to provide genotype prediction for HCMs.Methods: A convolutional neural network (CNN) was built with the 12-lead electrocardiogram (ECG) of 124 HCMs who underwent genetic testing (GT), externally tested by predicting the genotype on another HCMs cohort (n = 54), and compared with the conventional methods (the Mayo and Toronto score). Using a third cohort of HCMs (n = 76), the role of the network in risk stratification was explored by calculating the sudden cardiac death (SCD) risk scorers (HCM risk-SCD) across the predicted genotypes. Score-CAM was employed to provide a visual explanation of the network.Results: Overall, 80 of 178 HCMs (45%) were genotype-positive. Using the 12-lead ECG as input, the network showed an area under the curve (AUC) of 0.89 (95% CI, 0.83–0.96) on the test set, outperforming the Mayo score (0.69 [95% CI, 0.65–0.78], p < 0.001) and the Toronto score (0.69 [95% CI, 0.64–0.75], p < 0.001). The network classified the third cohort into two groups (predicted genotype-negative vs. predicted genotype-positive). Compared with the former, patients predicted genotype-positive had a significantly higher HCM risk-SCD (0.04 ± 0.03 vs. 0.03 ± 0.02, p <0.01). Visualization indicated that the prediction was heavily influenced by the limb lead.Conclusions: The network demonstrated a promising ability in genotype prediction and risk assessment in HCM.
first_indexed 2024-03-08T13:35:20Z
format Article
id doaj.art-6060da75db7e44018192f24cf4ee3118
institution Directory Open Access Journal
issn 0785-3890
1365-2060
language English
last_indexed 2024-03-08T13:35:20Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj.art-6060da75db7e44018192f24cf4ee31182024-01-16T19:13:22ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602023-12-0155110.1080/07853890.2023.2235564Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot studyLaiTe Chen0GuoSheng Fu1ChenYang Jiang2The Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou, P.R. ChinaSir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. ChinaSir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, P.R. ChinaAbstractObjective: Given the psychosocial and ethical burden, patients with hypertrophic cardiomyopathy (HCMs) could benefit from the establishment of genetic probability prior to the test. This study aimed to develop a simple tool to provide genotype prediction for HCMs.Methods: A convolutional neural network (CNN) was built with the 12-lead electrocardiogram (ECG) of 124 HCMs who underwent genetic testing (GT), externally tested by predicting the genotype on another HCMs cohort (n = 54), and compared with the conventional methods (the Mayo and Toronto score). Using a third cohort of HCMs (n = 76), the role of the network in risk stratification was explored by calculating the sudden cardiac death (SCD) risk scorers (HCM risk-SCD) across the predicted genotypes. Score-CAM was employed to provide a visual explanation of the network.Results: Overall, 80 of 178 HCMs (45%) were genotype-positive. Using the 12-lead ECG as input, the network showed an area under the curve (AUC) of 0.89 (95% CI, 0.83–0.96) on the test set, outperforming the Mayo score (0.69 [95% CI, 0.65–0.78], p < 0.001) and the Toronto score (0.69 [95% CI, 0.64–0.75], p < 0.001). The network classified the third cohort into two groups (predicted genotype-negative vs. predicted genotype-positive). Compared with the former, patients predicted genotype-positive had a significantly higher HCM risk-SCD (0.04 ± 0.03 vs. 0.03 ± 0.02, p <0.01). Visualization indicated that the prediction was heavily influenced by the limb lead.Conclusions: The network demonstrated a promising ability in genotype prediction and risk assessment in HCM.https://www.tandfonline.com/doi/10.1080/07853890.2023.2235564Genotypehypertrophic cardiomyopathyelectrocardiographygenetic testingdeep learningconvolutional neural network
spellingShingle LaiTe Chen
GuoSheng Fu
ChenYang Jiang
Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
Annals of Medicine
Genotype
hypertrophic cardiomyopathy
electrocardiography
genetic testing
deep learning
convolutional neural network
title Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
title_full Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
title_fullStr Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
title_full_unstemmed Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
title_short Deep learning-derived 12-lead electrocardiogram-based genotype prediction for hypertrophic cardiomyopathy: a pilot study
title_sort deep learning derived 12 lead electrocardiogram based genotype prediction for hypertrophic cardiomyopathy a pilot study
topic Genotype
hypertrophic cardiomyopathy
electrocardiography
genetic testing
deep learning
convolutional neural network
url https://www.tandfonline.com/doi/10.1080/07853890.2023.2235564
work_keys_str_mv AT laitechen deeplearningderived12leadelectrocardiogrambasedgenotypepredictionforhypertrophiccardiomyopathyapilotstudy
AT guoshengfu deeplearningderived12leadelectrocardiogrambasedgenotypepredictionforhypertrophiccardiomyopathyapilotstudy
AT chenyangjiang deeplearningderived12leadelectrocardiogrambasedgenotypepredictionforhypertrophiccardiomyopathyapilotstudy